rs35474657

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_000686.5(AGTR2):​c.971G>A​(p.Arg324Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000373 in 1,209,444 control chromosomes in the GnomAD database, including 1 homozygotes. There are 115 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0022 ( 1 hom., 58 hem., cov: 22)
Exomes 𝑓: 0.00019 ( 0 hom. 57 hem. )

Consequence

AGTR2
NM_000686.5 missense

Scores

17

Clinical Significance

Conflicting classifications of pathogenicity no assertion criteria provided U:1B:1

Conservation

PhyloP100: 4.59

Publications

9 publications found
Variant links:
Genes affected
AGTR2 (HGNC:338): (angiotensin II receptor type 2) The protein encoded by this gene belongs to the G-protein coupled receptor 1 family, and functions as a receptor for angiotensin II. It is an intergral membrane protein that is highly expressed in fetus and in neonates, but scantily in adult tissues, except brain, adrenal medulla, and atretic ovary. This receptor has been shown to mediate programmed cell death and this apoptotic function may play an important role in developmental biology and pathophysiology. Mutations in this gene are been associated with X-linked cognitive disability. Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and SARS-CoV-2 infection results in down-regulation of angiotensin converting enzyme-2 (ACE2) receptors, the effects of which, triggers serious inflammatory lesions in the tissues involved, primarily in the lungs. The inflammatory reaction appears to be mediated by angiotensin II derivatives, including the angiotensin AT2 receptor which has been found to be upregulated in bronchoalveolar lavage samples from Coronavirus disease 2019 (COVID19) patients. [provided by RefSeq, Jul 2020]
AGTR2 Gene-Disease associations (from GenCC):
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked complex neurodevelopmental disorder
    Inheritance: XL Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.05501291).
BP6
Variant X-116173251-G-A is Benign according to our data. Variant chrX-116173251-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 11718.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High Hemizygotes in GnomAd4 at 58 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AGTR2NM_000686.5 linkc.971G>A p.Arg324Gln missense_variant Exon 3 of 3 ENST00000371906.5 NP_000677.2 P50052
AGTR2NM_001385624.1 linkc.971G>A p.Arg324Gln missense_variant Exon 2 of 2 NP_001372553.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AGTR2ENST00000371906.5 linkc.971G>A p.Arg324Gln missense_variant Exon 3 of 3 1 NM_000686.5 ENSP00000360973.4 P50052
AGTR2ENST00000681852.1 linkc.971G>A p.Arg324Gln missense_variant Exon 2 of 2 ENSP00000505750.1 P50052
AGTR2ENST00000680409.1 linkn.1439G>A non_coding_transcript_exon_variant Exon 1 of 1

Frequencies

GnomAD3 genomes
AF:
0.00214
AC:
238
AN:
111443
Hom.:
1
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00748
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000385
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000377
Gnomad OTH
AF:
0.00203
GnomAD2 exomes
AF:
0.000552
AC:
101
AN:
183068
AF XY:
0.000384
show subpopulations
Gnomad AFR exome
AF:
0.00722
Gnomad AMR exome
AF:
0.000110
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000123
Gnomad OTH exome
AF:
0.000443
GnomAD4 exome
AF:
0.000192
AC:
211
AN:
1097949
Hom.:
0
Cov.:
31
AF XY:
0.000157
AC XY:
57
AN XY:
363421
show subpopulations
African (AFR)
AF:
0.00713
AC:
188
AN:
26378
American (AMR)
AF:
0.000142
AC:
5
AN:
35185
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19368
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30203
South Asian (SAS)
AF:
0.0000185
AC:
1
AN:
54132
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
40532
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4137
European-Non Finnish (NFE)
AF:
0.00000713
AC:
6
AN:
841927
Other (OTH)
AF:
0.000239
AC:
11
AN:
46087
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
12
24
35
47
59
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00215
AC:
240
AN:
111495
Hom.:
1
Cov.:
22
AF XY:
0.00172
AC XY:
58
AN XY:
33731
show subpopulations
African (AFR)
AF:
0.00752
AC:
231
AN:
30700
American (AMR)
AF:
0.000384
AC:
4
AN:
10405
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2646
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3519
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2691
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6042
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.0000377
AC:
2
AN:
53093
Other (OTH)
AF:
0.00200
AC:
3
AN:
1500
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
10
20
29
39
49
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000568
Hom.:
24
Bravo
AF:
0.00216
ESP6500AA
AF:
0.00730
AC:
28
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000692
AC:
84
EpiCase
AF:
0.00
EpiControl
AF:
0.000119

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

not provided Uncertain:1
Aug 08, 2013
OMIM
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:literature only

- -

AGTR2-related disorder Benign:1
Dec 23, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.69
T
BayesDel_noAF
Benign
-0.76
CADD
Benign
16
DANN
Benign
0.76
DEOGEN2
Benign
0.17
T
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.79
T
M_CAP
Benign
0.0024
T
MetaRNN
Benign
0.055
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
PhyloP100
4.6
PrimateAI
Benign
0.34
T
PROVEAN
Benign
0.0
N
REVEL
Benign
0.086
Sift
Benign
0.83
T
Sift4G
Benign
0.68
T
Polyphen
0.012
B
Vest4
0.082
MVP
0.82
MPC
0.16
ClinPred
0.016
T
GERP RS
1.7
Varity_R
0.19
gMVP
0.24
Mutation Taster
=91/9
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35474657; hg19: chrX-115304504; API